Does the product no. 5010, anti-human C5b-9 antibody bind both the soluble and membrane bound form of the TCC complex?
This antibody recognises C5b-9, the terminal complement complex (TCC) and is directed against a neoepitope exposed in C9 when incorporated into the terminal complement complex (TCC). The clone aE11 produces monoclonal antibodies against neoantigens of both membrane bound (MAC) and fluid phase (SC5b-9) complexes. Read more.